HUMAN DISEASE MODELED by cdc16^s517/s517 (TL)
No data available

GENE EXPRESSION
Gene expression in cdc16^s517/s517 (TL)

PHENOTYPE
Phenotype in cdc16^s517/s517 (TL)

Phenotype	Conditions	Figures
ceratobranchial 3 cartilage decreased length, abnormal	standard conditions	Fig. S3 from Wehman et al., 2007
ceratobranchial 4 cartilage decreased length, abnormal	standard conditions	Fig. S3 from Wehman et al., 2007
ceratobranchial 5 cartilage decreased length, abnormal	standard conditions	Fig. S3 from Wehman et al., 2007
chromosome segregation process quality, abnormal	control	Fig. 3 from Wehman et al., 2007
ciliary marginal zone decreased size, abnormal	standard conditions	Fig. 1 from Wehman et al., 2007
ciliary marginal zone spindle apical-basal polarity, abnormal	control	Fig. 3 from Wehman et al., 2007
ciliary marginal zone spindle increased amount, abnormal	control	Fig. 3 from Wehman et al., 2007
ciliary marginal zone spindle orientation retinal pigmented epithelium, abnormal	control	Fig. 3 from Wehman et al., 2007
ciliary marginal zone spindle structure, abnormal	control	Fig. 3 from Wehman et al., 2007
eye apoptotic, abnormal	control	Fig. 2 from Wehman et al., 2007
eye decreased size, abnormal	standard conditions	Fig. 1 from Wehman et al., 2007
fin morphology, abnormal	chemical treatment: 5-bromo-2'-deoxyuridine	Fig. 6 from Wehman et al., 2007
mitotic cell cycle arrested, abnormal	control	Fig. 2 from Wehman et al., 2007
olfactory epithelium morphology, abnormal	standard conditions	text only from Wehman et al., 2007
regulation of cell cycle increased duration, abnormal	control	Fig. 3 from Wehman et al., 2007
regulation of mitotic cell cycle disrupted, abnormal	chemical treatment: 5-bromo-2'-deoxyuridine	Fig. 6 from Wehman et al., 2007
retina morphology, normal	standard conditions	Fig. 1 from Wehman et al., 2007
swim bladder inflation arrested, abnormal	standard conditions	Fig. 1 from Wehman et al., 2007
whole organism apoptotic, abnormal	chemical treatment: N-phenylthiourea	Fig. 6 from Wehman et al., 2007